SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Amanta Healthcare - Quaterly Results

11 Feb 2026 Evaluate
The company witnessed a 9.84% growth in the revenue at Rs. 744.87 millions for the quarter ended December 2025 as compared to Rs. 678.15 millions during the year-ago period.Modest increase of 8.08% in the Net Profit was reported from. 42.81 millions to Rs. 46.27  millions.Operating profit for the quarter ended December 2025 rose to 160.37 millions as compared to 159.32 millions of corresponding quarter ended December 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202512 202412 % Var
Sales 744.87 678.15 9.84 744.87 678.15 9.84 744.87 678.15 9.84
Other Income 6.77 8.70 -22.18 6.77 8.70 -22.18 6.77 8.70 -22.18
PBIDT 160.37 159.32 0.66 160.37 159.32 0.66 160.37 159.32 0.66
Interest 50.61 58.98 -14.19 50.61 58.98 -14.19 50.61 58.98 -14.19
PBDT 109.76 100.34 9.39 109.76 100.34 9.39 109.76 100.34 9.39
Depreciation 46.74 45.05 3.75 46.74 45.05 3.75 46.74 45.05 3.75
PBT 63.02 55.29 13.98 63.02 55.29 13.98 63.02 55.29 13.98
TAX 16.75 12.48 34.21 16.75 12.48 34.21 16.75 12.48 34.21
Deferred Tax -3.66 1.27 -388.19 -3.66 1.27 -388.19 -3.66 1.27 -388.19
PAT 46.27 42.81 8.08 46.27 42.81 8.08 46.27 42.81 8.08
Equity 343.36 282.70 21.46 343.36 282.70 21.46 343.36 282.70 21.46
PBIDTM(%) 21.53 23.49 -8.36 21.53 23.49 -8.36 21.53 23.49 -8.36

Amanta Healthcare Share Price

130.37 1.47 (1.14%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×